Related references
Note: Only part of the references are listed.Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences
Najah Abi-Gerges et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam
Dyfrig A. Hughes
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
Moussa Saleh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
Ehud Chorin et al.
HEART RHYTHM (2020)
Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019
Yishay Szekely et al.
HEART RHYTHM (2020)
COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias
Lia Crotti et al.
HEART RHYTHM (2020)
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
Lior Jankelson et al.
HEART RHYTHM (2020)
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
Satyajit Tripathy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Human Purkinje in silico model enables mechanistic investigations into automaticity and pro-arrhythmic abnormalities
Cristian Trovato et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Chloroquine-induced QTc prolongation in COVID-19 patients
M. P. H. van den Broek et al.
NETHERLANDS HEART JOURNAL (2020)
Multiparametric Mechanistic Profiling of Inotropic Drugs in Adult Human Primary Cardiomyocytes
Najah Abi-Gerges et al.
SCIENTIFIC REPORTS (2020)
Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?
Timothy J. Kamp et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro et al.
JAMA CARDIOLOGY (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Effects of hydroxychloroquine treatment on QT interval
Matthew Hooks et al.
HEART RHYTHM (2020)
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
Arianna Pani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Cardiac effects and toxicity of chloroquine: a short update
Kanigula Mubagwa
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Samia Arshad et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China
Dong Chen et al.
JAMA NETWORK OPEN (2020)
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
John R. Giudicessi et al.
MAYO CLINIC PROCEEDINGS (2020)
Discovery and characterization of ORM-11372, a novel inhibitor of the sodium-calcium exchanger with positive inotropic activity
Leena Otsomaa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19
Marinella Lauriola et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19 (vol 84, pg 913, 2020)
Bo Yu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Jean-Christophe Lagier et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Drug-induced 'Torsade de Pointes' in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report
Edimir Semedo et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2020)
Toxicokinetics of hydroxychloroquine following a massive overdose
Jonathan de Olano et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)
Workshop Report FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms
Li Pang et al.
CIRCULATION RESEARCH (2019)
Optimization of cardiac CiPA targets (hCav1.2 and hKCNQ1/hminK) on the QPatch HT automated system
Bryan J. Koci et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Revisiting the Cardiotoxic Effect of Chloroquine
Marguerite Blignaut et al.
CARDIOVASCULAR DRUGS AND THERAPY (2019)
Systemic lupus erythematosus: Diagnosis and clinical management
Andrea Fava et al.
JOURNAL OF AUTOIMMUNITY (2019)
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
Clotilde Chatre et al.
DRUG SAFETY (2018)
Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae
Yusheng Qu et al.
FRONTIERS IN PHYSIOLOGY (2018)
The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
Ilsa L. Haeusler et al.
BMC MEDICINE (2018)
2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Ashish R. Panchal et al.
CIRCULATION (2018)
HYDROXYCHLOROQUINE OVERDOSE PRESENTING AS ACQUIRED QT INTERVAL PROLONGATION AND TORSADE DE POINTES
Ifesinachi Ndukwu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Adult Human Primary Cardiomyocyte-Based Model for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-arrhythmia Risk
Nathalie Nguyen et al.
FRONTIERS IN PHYSIOLOGY (2017)
Quantitative Comparison of Effects of Dofetilide, Sotalol, Quinidine, and Verapamil between Human Ex vivo Trabeculae and In silico Ventricular Models Incorporating Inter-Individual Action Potential Variability
Oliver J. Britton et al.
FRONTIERS IN PHYSIOLOGY (2017)
Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin
Mengdan Zhang et al.
CARDIOVASCULAR TOXICOLOGY (2017)
Azithromycin Causes a Novel Proarrhythmic Syndrome
Zhenjiang Yang et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Human ex-vivo action potential model for pro-arrhythmia risk assessment
Guy Page et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
William J. Crumb et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative Update on progress
Thomas Colatsky et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential
Rebecca A. Capel et al.
HEART RHYTHM (2015)
Assessing drug safety in human tissues - what are the barriers?
Anthony Holmes et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes
Hiroshi Ohara et al.
CARDIOVASCULAR TOXICOLOGY (2015)
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Philip T. Sager et al.
AMERICAN HEART JOURNAL (2014)
Cardiovascular risks of antibiotics
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2014)
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
Gowtham A. Rao et al.
ANNALS OF FAMILY MEDICINE (2014)
Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus Erythematosus
Nadia D. Morgan et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2013)
Hydroxychloroquine: From Malaria to Autoimmunity
Ilan Ben-Zvi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Validation of an in vitro contractility assay using canine ventricular myocytes
A. R. Harmer et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Mechanisms of hypokalemia-induced ventricular arrhythmogenicity
Oleg E. Osadchii
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2010)
Electrophysiological determinants of hypokalaemia-induced arrhythmogenicity in the guinea-pig heart
O. E. Osadchii et al.
ACTA PHYSIOLOGICA (2009)
Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative
Jonathan P. Piccini et al.
AMERICAN HEART JOURNAL (2009)
Azithromycin-induced torsade de pointes
Bien-Hsien Huang et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2007)
Azithromycin/Chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig
Anthony A. Fossa et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors
Anna Kezerashvili et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2007)
Pro-arrhythmic effects of amiodarone and concomitant rate-control medication
Jan Wilko Schrickel et al.
EUROPACE (2006)
Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
CY Chen et al.
CLINICAL TOXICOLOGY (2006)
Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells
M Traebert et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts
JL Pasquié et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2004)
Torsade de piontes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome
E Arellano-Rodrigo et al.
MEDICINA CLINICA (2001)
Share Paper
